Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian ipilimumab expanded access programme (EAP)Paolo A. Ascierto, Michele Maio, Paola Queirolo et al.|Journal for ImmunoTherapy of Cancer|2013Cited by 4